Citius Oncology Inc (CTOR)

$1.27 -0.05 (-3.79%)
Market Cap 90.87M
Revenue (ttm) 0.00
Net Income (ttm) -21.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.10
Volume 92,300
Avg Vol 2,365,538
Day's Range N/A - N/A
Shares Out 71.55M
Stochastic %K 40%
Beta -0.64
Analysts Strong Sell
Price Target $3.00

Latest News on CTOR

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Jan 7, 2025, 8:08 AM EST - 11 days ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

CTXR

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Jan 6, 2025, 7:50 AM EST - 12 days ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

CTXR

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Dec 27, 2024, 5:00 PM EST - 22 days ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update